Thammasat University Hospital is a public hospital subsidiary to the Office of the Rector, Thammasat University, Ministry of Education. It is located in the Rangsit Campus, Pathum Thani Province, Thailand.

There are 439 beds in Thammasat University Hospital.

During the past decade, Thammasat University Hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 8 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 7 clinical trials were completed. i.e. 77.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Thammasat University Hospital" #1 sponsor was "Thammasat University" with 8 trials, followed by "Alexion" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Imunon" with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Thammasat University Hospital" #1 collaborator was "Boontanapibul, Krit, M.D." with 3 trials as a collaborator, "Bangkok Drug company" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator, "MEDA Pharma GmbH & Co. KG" with 1 trials as a collaborator and "Novotech (Australia) Pty Limited" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Thammasat University Hospital" are "Atrial Fibrillation" (2 trials), "Hepatocellular Carcinoma" (2 trials), "Knee Osteoarthritis" (2 trials), "Neuromyelitis Optica" (2 trials) and "Neuromyelitis Optica Spectrum Disorder" (2 trials). Many other conditions were trialed in "Thammasat University Hospital" in a lesser frequency.

Most popular intervention types in "Thammasat University Hospital" are "Drug" (18 trials), "Procedure" (5 trials), "Biological" (2 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ThermoDox" (2 trials), "placebo" (2 trials), "0.075% Capsaicin Lotion" (1 trials) and "0.5% bupivacaine 100 mg, morphine sulfate 5 mg, 0.1% epinephrine 0.6 mg, and ketorolac 30 mg mixed NSS up to 100 mL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Thammasat University Hospital" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Thammasat University Hospital". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Thammasat University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Thammasat University Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".